LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
Abstract Background Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is overexpressed in multiple human tumors. However, the role of LPCAT1 in hepatocellular carcinoma (HCC) has not been understood. We aim to explore the relationships between LPCAT1 expression and prognosis, clinicopathological fe...
Main Authors: | Lan Li, Xiao Wang, Yanni Ding, Nini Hui, Bingjie Su, Min Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-022-00854-1 |
Similar Items
-
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
by: Lin T, et al.
Published: (2021-11-01) -
Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration
by: Qingqing Wang, et al.
Published: (2023-04-01) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
by: Xin Jin, et al.
Published: (2021-11-01) -
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
by: Hongbin Zhang, et al.
Published: (2022-01-01) -
Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
by: Tianyi Zhao, et al.
Published: (2021-05-01)